Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
734.97 | -46,29% | -24,25% | 661.770,95 | 0,69% | 2,63% |
|
NYSE:JNJ
Johnson & Johnson
|
149.27 | 0% | 0% | 359.245 | 3,31% | 2,71% |
|
NYSE:MRK
Merck
|
127.51 | -7,42% | 6,15% | 322.986,42 | 2,4% | -19,03% |
|
NYSE:PFE
Pfizer
|
27.81 | 11,74% | 42,95% | 157.475,27 | 6,06% | -9,31% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
401.08 | 8,66% | 17,27% | 103.662,87 | 0% | 30,14% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
957.00 | -27,73% | -21,57% | 105.447,53 | 0% | 13,9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
43.99 | 61,89% | 72,23% | 89.172,13 | 5,49% | 13,54% |
|
NYSE:ZTS
Zoetis
|
167.07 | 32,43% | 48,83% | 76.342,17 | 1,03% | 11,19% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
152.33 | 0% | 0% | 19.268,49 | 0% | 0% |
|
NYSE:BAX
Baxter International Inc
|
36.89 | 74,74% | 101,09% | 18.798,41 | 3,14% | -3,14% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.78 | 1,95% | 12,16% | 13.740,18 | 4,14% | -8,55% |
|
NasdaqGS:UTHR
United Therapeutics
|
262.40 | -9,47% | 0,04% | 11.641,77 | 0% | 5,22% |
|
NYSE:CTLT
Catalent
|
56.50 | -57,67% | -7,64% | 10.225,04 | 0% | -10,41% |
|
NasdaqGS:CYTK
Cytokinetics
|
65.27 | 0% | 0% | 6.838,6 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
41.97 | -.153,3% | -.146,3% | 6.121,15 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
150.40 | -0,56% | 9% | 4.561,9 | 0,54% | 5,85% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
229.84 | 0% | 0% | 4.342,48 | 0% | 0% |
|
NasdaqGS:NEOG
Neogen
|
12.02 | 135,45% | 235,73% | 2.670,77 | 0% | -1,7% |
|
LSE:INDV
Indivior PLC
|
14.35 | -23,61% | -1,68% | 1.952,43 | 0% | -2,7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
24.52 | -34,78% | -10,92% | 2.552,83 | 0% | 2,03% |
